Form Bio Co. Ltd. (377220) — Cash Flow Reinvestment Rate

Latest as of September 2022: 3.43x

Form Bio Co. Ltd. (377220) has a Cash Flow Reinvestment Rate of 3.43x as of September 2022, reinvesting ₩10.55 Billion (capex ₩10.55 Billion ) from operating cash flow of ₩3.08 Billion. Check cash flow quality index of Form Bio Co. Ltd. to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

3.43x
(Capex + Investments) / Operating CF

Total Reinvested

₩10.55 Billion
Capex + Investments

Operating Cash Flow

₩3.08 Billion
KRW

Capital Expenditures

₩10.55 Billion
KRW

Form Bio Co. Ltd. Cash Flow Reinvestment Rate (2019–2020)

Historical reinvestment intensity for Form Bio Co. Ltd. across 2 annual periods. Explore Form Bio Co. Ltd. (377220) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Form Bio Co. Ltd. (2019–2020)

Year-by-year capital reinvestment analysis for Form Bio Co. Ltd.. For live market cap and broader valuation context, see 377220 stock market capitalisation.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2020 0.99x ₩15.40 Billion ₩15.61 Billion ₩6.63 Billion ▲ +145.3%
2019 0.40x ₩2.28 Billion ₩5.68 Billion ₩2.28 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow